Description
This assay uses the Luminex® 200™ platform.
Consider this assay for a focused analysis of CD8+ T cell-associated markers. The Human CD8+ 5-Plex Discovery Assay® Array measures key biomarkers involved in cytotoxic T cell activity and immune regulation.
Ideal for research on immune responses in cancer and viral infections, this assay provides insights into markers like Granzyme B and Perforin, which are crucial for T cell-mediated cytotoxicity. For instance, Granzyme B is involved in inducing apoptosis in target cells, while Perforin facilitates the delivery of cytotoxic molecules.
The assay’s biomarkers also include Granzyme A, which plays a role in cell apoptosis, and sFas and sFas Ligand, which are involved in regulating programmed cell death and immune responses.
This panel is particularly valuable for studying immune surveillance mechanisms, evaluating immune system dysfunctions, and developing immunotherapies. It can also aid in understanding the dynamics of T cell-mediated responses in various disease states and therapeutic contexts. Additionally, it is useful for profiling the functional status of cytotoxic T cells in research on autoimmune diseases.
Discover the power of precision with our Human CD8+ 5-Plex Discovery Assay® Array, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency. Streamline your research and unlock a new level of detail with our advanced multiplex assay solution.
Click here for information on shipping biological samples for Discovery Assays